← Back to Clinical Trials
Recruiting NCT07248566

NCT07248566 Cognitive Sensory Motor Training Therapy for Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07248566
Status Recruiting
Phase
Sponsor Riphah International University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2025-10-28
Primary Completion 2026-01-02

Eligibility & Interventions

Sex Female only
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Cognitive Sensory Motor Training Therapyconventional occupational therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2025-10-28 with a primary completion date of 2026-01-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study will be randomized controlled trial, data will be collected from Central Park Teaching Hospital. The study will include 32 participants equally divided into two groups and randomly allocated. Inclusion criteria for this study will be consist of diagnosis with cerebral palsy, age 6-12, ability to participate in cognitive sensory motor training therapy, stable medical condition, and informed consent from parents/guardians. Participants with severe cognitive impairments, unstable medical condition, history of spinal cord injury or deformity, diagnosis with other neurological conditions, and visual or hearing impairments will be excluded from the study.. The Experimental group will receive Cognitive Sensory Motor Training Therapy and Routine Physical Therapy, while the Control group will receive Routine Physical Therapy.Cognitive Sensory Motor Training Therapy (CSMT) for 35 minutes, five times a week, over 12 weeks. Data collection will be done before and after the interventions.Outcome measures will include the dexterity, and upper limb function.Tools used for data collection will be Action Research Arm Test and Box and Block Test. Data analysis will utilize SPSS version 25.00.

Eligibility Criteria

Inclusion Criteria: * Children aged 6-12 years with cerebral palsy * Diagnosis confirmed by pediatric neurologist or rehabilitation specialist * Ability to follow simple instructions and participate in therapy sessions. * Participants had to be able to focus attention on demonstrate level II and III on the Gross * Motor Function Classification Scale (GMFCS) * Level II or III on the Manual Ability Classification System (MACS) Exclusion Criteria: * Visual impairment or hearing defect * Severe cognitive decline and aphasia * Contractures that could limit the patient from maintaining the extended arm in a comfortable position,

Contact & Investigator

Central Contact

Imran Amjad, PHD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Sadia Javed, MS-PT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07248566 clinical trial?

This trial is open to female participants only, aged 6 Years or older, up to 12 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07248566 currently recruiting?

Yes, NCT07248566 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07248566 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07248566 clinical trial?

NCT07248566 is sponsored by Riphah International University. The principal investigator is Sadia Javed, MS-PT at Riphah International University. The trial plans to enroll 32 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology